Earnings Feed
Start Free
Arno Therapeutics, Inc·4

Apr 11, 4:22 PM ET

Arno Therapeutics, Inc 4

4 · Arno Therapeutics, Inc · Filed Apr 11, 2016

Insider Transaction Report

Form 4
Period: 2016-04-07
Arno Therapeutics, IncARNI
Reizman Yacov
Director
Transactions
  • Award

    Stock Option (right to buy)

    2016-04-07+88,628→ 88,628 total
    Exercise: $0.37Exp: 2026-04-07→ Common Stock (88,628 underlying)
Holdings

  • Stock Option (right to buy)

    Exercise: $8.00Exp: 2020-11-05→ Common Stock (3,750 underlying)
    3,750

  • Common Stock

    (indirect: By FCC Ltd.)
    38,285

  • Stock Option (right to buy)

    Exercise: $2.40Exp: 2023-11-04→ Common Stock (68,448 underlying)
    68,448

  • Stock Option (right to buy)

    Exercise: $2.90Exp: 2024-01-24→ Common Stock (34,224 underlying)
    34,224
Footnotes (4)
  • [F1]The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  • [F2]Currently exercisable.
  • [F3]Vests in equal 36-monthly installments commencing 12/4/13.
  • [F4]Vests in equal 12-monthly installments commencing 5/7/16.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT